Yi Huan

7.3k total citations · 1 hit paper
68 papers, 2.7k citations indexed

About

Yi Huan is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yi Huan has authored 68 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 26 papers in Surgery and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yi Huan's work include Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (19 papers) and Metabolism, Diabetes, and Cancer (15 papers). Yi Huan is often cited by papers focused on Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (19 papers) and Metabolism, Diabetes, and Cancer (15 papers). Yi Huan collaborates with scholars based in China, United States and Austria. Yi Huan's co-authors include Chengyu Jiang, Keiji Kuba, Yumiko Imai, Feng Guo, Michael A. Crackower, Renu Sarao, Teiji Wada, Howard Leong‐Poi, Stefan Uhlig and Xiaozhong Peng and has published in prestigious journals such as Nature, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yi Huan

65 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-converting enzyme 2 protects from severe acute lung failure

2005 1.8k citations Yi Huan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Huan China	21	1.3k	700	459	401	332	68	2.7k
Wenshan Lv China	14	376 0.3×	410 0.6×	208 0.5×	143 0.4×	111 0.3×	32	1.5k
Alessandro Di Minno Italy	31	209 0.2×	580 0.8×	156 0.3×	263 0.7×	737 2.2×	125	3.0k
Khalid Al‐Rasadi Oman	31	324 0.3×	580 0.8×	123 0.3×	724 1.8×	561 1.7×	114	3.0k
Rosaria Vincenza Giglio Italy	30	221 0.2×	582 0.8×	179 0.4×	701 1.7×	176 0.5×	91	2.5k
Toshimitsu Ito Japan	20	524 0.4×	476 0.7×	101 0.2×	264 0.7×	121 0.4×	49	1.9k
David M. Kornhauser United States	24	274 0.2×	671 1.0×	112 0.2×	800 2.0×	290 0.9×	48	2.3k
Jennifer A. Buffa United States	20	433 0.3×	4.0k 5.8×	76 0.2×	411 1.0×	477 1.4×	31	5.8k
Vittoria Cammisotto Italy	23	173 0.1×	676 1.0×	115 0.3×	229 0.6×	354 1.1×	92	2.4k
Lin Ding China	26	151 0.1×	528 0.8×	114 0.2×	296 0.7×	167 0.5×	63	2.0k

Countries citing papers authored by Yi Huan

Since Specialization

Citations

This map shows the geographic impact of Yi Huan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Huan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Huan more than expected).

Fields of papers citing papers by Yi Huan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Huan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Huan. The network helps show where Yi Huan may publish in the future.

Co-authorship network of co-authors of Yi Huan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Huan. A scholar is included among the top collaborators of Yi Huan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Huan. Yi Huan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Wei, Yongguo Li, Ai Huang, et al.. (2025). Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy. Molecular Metabolism. 96. 102151–102151. 1 indexed citations

Huan, Yi, et al.. (2024). Effect of sodium alginate and egg white protein combinations on the functional properties and structures of chicken myofibrillar protein. Food Research International. 196. 115071–115071. 11 indexed citations

Huan, Yi, et al.. (2024). Reference Gene Selection and Gene Expression Analysis during Gall Development of Zizania latifolia. Horticulturae. 10(7). 759–759.

Tong, Qin, Xuefeng Gao, Lei Lei, et al.. (2023). Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease. European Journal of Medicinal Chemistry. 252. 115307–115307. 8 indexed citations

Yu, Peng, Yi Huan, Jingjing Chen, et al.. (2023). Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity. Frontiers in Microbiology. 14. 1148513–1148513. 5 indexed citations

Gao, Shuang, et al.. (2023). Eukaryotic Translation Elongation Factor OsEF1A Positively Regulates Drought Tolerance and Yield in Rice. Plants. 12(14). 2593–2593. 7 indexed citations

Huan, Yi. (2023). Correlation of Uric Acid with Disease Severity, Prognosis, and Complications in Patients with Severe Acute Pancreatitis. Frontiers in Medical Science Research. 5(4). 2 indexed citations

Li, Caina, Quan Liu, Hui Cao, et al.. (2023). New anti-diabetic drug Morus alba L. (Sangzhi) alkaloids (SZ-A) improves diabetic nephropathy through ameliorating inflammation and fibrosis in diabetic rats. Frontiers in Medicine. 10. 1164242–1164242. 7 indexed citations

Liu, Xingfeng, Kai Wang, Shaocong Hou, et al.. (2022). Insulin induces insulin receptor degradation in the liver through EphB4. Nature Metabolism. 4(9). 1202–1213. 21 indexed citations

10.

Huan, Yi, Shuainan Liu, Caina Li, et al.. (2022). Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells. International Journal of Molecular Sciences. 23(19). 11215–11215. 12 indexed citations

11.

Wang, Xing, Caina Li, Yi Huan, et al.. (2021). Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation. Chemico-Biological Interactions. 338. 109427–109427. 20 indexed citations

12.

Li, Caina, Xing Wang, Sujuan Sun, et al.. (2020). Effects of a ready‐to‐eat cereal formula powder on glucose metabolism, inflammation, and gut microbiota in diabetic db/db mice. Food Science & Nutrition. 8(8). 4523–4533. 6 indexed citations

13.

Lei, Lei, Guoliang Bai, Xing Wang, et al.. (2020). Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection. Toxicology and Applied Pharmacology. 406. 115189–115189. 7 indexed citations

14.

Wang, Xing, Lei Lei, Minzhi Liu, et al.. (2019). Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Phytotherapy Research. 34(5). 1166–1174. 49 indexed citations

15.

Huan, Yi, Xuan Pan, Jun Peng, et al.. (2019). A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice. Diabetes Obesity and Metabolism. 21(11). 2553–2563. 17 indexed citations

16.

Zhou, Tianhua, Xuan Pan, Ying Yang, et al.. (2018). Design, synthesis and biological evaluation of a series of novel GPR40 agonists containing nitrogen heterocyclic rings. Bioorganic & Medicinal Chemistry Letters. 28(18). 3050–3056. 12 indexed citations

17.

Huan, Yi, Qian Jiang, Gang Li, et al.. (2017). The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Scientific Reports. 7(1). 4351–4351. 28 indexed citations

18.

Liu, Quan, Shuainan Liu, Sujuan Sun, et al.. (2017). Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KKAy mice. Acta Pharmaceutica Sinica B. 7(4). 461–469. 37 indexed citations

19.

Wang, Fang, Jing Ren, Xiuchun Qiu, et al.. (2010). Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence. Clinical Cancer Research. 16(8). 2284–2294. 19 indexed citations

20.

Zhang, Ning, Yi Huan, Hui Huang, et al.. (2009). Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. Acta Pharmacologica Sinica. 31(1). 35–42. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact